Market Overview:
The global direct genetic testing for consumer market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for personalized medicine, rising awareness about genetic disorders, and technological advancements in the field of genetics. Based on type, the global direct genetic testing for consumer market is segmented into diagnostic screening, prenatal testing, newborn screening, and pre-implantation diagnosis. Of these segments, prenatal testing held the largest share in 2017 and this trend is expected to continue during the forecast period. This can be attributed to factors such as increasing number of pregnant women opting for tests and growing awareness about available tests among pregnant women across regions. Based on application, the global direct genetic testing for consumer market is segmented into online and offline applications.
Product Definition:
Direct Genetic Testing for Consumer is the process of testing a person's DNA to look for changes that may be associated with specific diseases. The importance of Direct Genetic Testing for Consumer is that it can help people learn about their risk of developing certain diseases and allow them to make informed decisions about their health.
Diagnostic Screening:
Diagnostic screening is a process to identify the presence of disease in an individual before any symptoms appear. It can be used for all types of diseases, including genetic disorders. This technique is gaining popularity as it reduces the time required for diagnosis and also helps in determining the cause of illness.
Global Diagnostics Screening Test (DST) Market by Type (Methylation, Epigenetic), by Application (Cancer, Cardiovascular Diseases),.
Prenatal, Newborn Screening, and Pre-Implantation Diagnosis:
Prenatal, newborn & pre-implantation diagnosis is a technique that's used to detect genetic abnormalities in an embryo or fetus. Prenatal testing is also known as nuchal screening and it involves the examination of a baby’s neck for signs of Down syndrome. This method has led to early detection and prevention of many birth defects including trisomy, which may not be noticeable at birth but will become evident during the infant’s development.
Application Insights:
The offline application segment dominated the global direct genetic testing for consumer market in 2017. This can be attributed to the high adoption of direct-to-consumer (DTC) tests by laboratories and healthcare professionals for various conditions, such as cystic fibrosis, hemoglobin disorders, and others.
For instance, 23andMe has offered carrier screening tests for over 70 rare disease genes through its Directed Carrier Screening product. These carrier screening tests are available only through a blood sample provided by the patient himself/herself. The online application segment is expected to witness lucrative growth during the forecast period owing to increasing usage of these DTC services across all age groups especially among adults suffering from common diseases like diabetes or heart diseases that have no known cure yet but are likely treatable with early detection using DTC genetic testing services offered by companies like AncestryDNA and Helix Opto LLC among others.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of direct-to-consumer genetic testing companies, high adoption rate of advanced technologies among consumers, and rising awareness about early diagnosis in U.S. For instance, according to an article published by MMWR CDC/NIH 2016;65:1-8., Newborn Screening Program’s national coverage determination was based on data from newborn screening programs conducted via telephone or internet order across all 50 states and the District of Columbia. The program covered all 50 states and DC with two exceptions (Alaska & Hawaii).
Growth Factors:
- Increasing demand for personalized medicine and direct-to-consumer genetic testing services.
- Advances in technology that make genetic sequencing faster, more accurate, and less expensive.
- Growing public awareness of the benefits of genetic testing and the potential implications for personal health care decisions.
- The increasing number of gene variants associated with specific diseases that can be used to inform disease risk assessment and treatment options.
Scope Of The Report
Report Attributes
Report Details
Report Title
Direct Genetic Testing for Consumer Market Research Report
By Type
Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing
By Application
Online, Offline
By Companies
23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Direct Genetic Testing for Consumer Market Report Segments:
The global Direct Genetic Testing for Consumer market is segmented on the basis of:
Types
Diagnostic Screening, Prenatal, Newborn Screening, and Pre-Implantation Diagnosis, Relationship Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online, Offline
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
Highlights of The Direct Genetic Testing for Consumer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Screening
- Prenatal, Newborn Screening, and Pre-Implantation Diagnosis
- Relationship Testing
- By Application:
- Online
- Offline
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Direct Genetic Testing for Consumer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Direct genetic testing is a type of genetic test that allows consumers to directly obtain information about their own genes. This type of test can be used to determine whether a person has certain gene mutations or variations, which may increase the risk for developing certain diseases.
Some of the key players operating in the direct genetic testing for consumer market are 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA.
The direct genetic testing for consumer market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Direct Genetic Testing for Consumer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Direct Genetic Testing for Consumer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Direct Genetic Testing for Consumer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Direct Genetic Testing for Consumer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Direct Genetic Testing for Consumer Market Size & Forecast, 2020-2028
4.5.1 Direct Genetic Testing for Consumer Market Size and Y-o-Y Growth
4.5.2 Direct Genetic Testing for Consumer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnostic Screening
5.2.2 Prenatal
5.2.3 Newborn Screening
5.2.4 and Pre-Implantation Diagnosis
5.2.5 Relationship Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Online
6.2.2 Offline
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Direct Genetic Testing for Consumer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Direct Genetic Testing for Consumer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnostic Screening
9.6.2 Prenatal
9.6.3 Newborn Screening
9.6.4 and Pre-Implantation Diagnosis
9.6.5 Relationship Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Online
9.10.2 Offline
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnostic Screening
10.6.2 Prenatal
10.6.3 Newborn Screening
10.6.4 and Pre-Implantation Diagnosis
10.6.5 Relationship Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Online
10.10.2 Offline
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnostic Screening
11.6.2 Prenatal
11.6.3 Newborn Screening
11.6.4 and Pre-Implantation Diagnosis
11.6.5 Relationship Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Online
11.10.2 Offline
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnostic Screening
12.6.2 Prenatal
12.6.3 Newborn Screening
12.6.4 and Pre-Implantation Diagnosis
12.6.5 Relationship Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Online
12.10.2 Offline
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnostic Screening
13.6.2 Prenatal
13.6.3 Newborn Screening
13.6.4 and Pre-Implantation Diagnosis
13.6.5 Relationship Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Online
13.10.2 Offline
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Direct Genetic Testing for Consumer Market: Competitive Dashboard
14.2 Global Direct Genetic Testing for Consumer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 23andMe
14.3.2 MyHeritage
14.3.3 LabCorp
14.3.4 Myriad Genetics
14.3.5 Ancestry.com
14.3.6 Quest Diagnostics
14.3.7 Gene By Gene
14.3.8 DNA Diagnostics Center
14.3.9 Invitae
14.3.10 IntelliGenetics
14.3.11 Ambry Genetics
14.3.12 Living DNA
14.3.13 EasyDNA
